Journal of Korean Clinical Nursing Research (임상간호연구)

Hospital Nurses Association (병원간호사회)
권호 표지
DOI QR코드

DOI QR Code

Factors Influencing Distress in Premenopausal Patients with Breast Cancer Undergoing Endocrine Therapy

내분비요법 중인 폐경 전 유방암 환자의 디스트레스 영향 요인

  • Received : 2019.01.09
  • Accepted : 2019.02.22
  • Published : 2019.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The purpose of this study was to investigate relationships among menopausal symptoms, functional status, and distress and to identify factors influencing distress in premenopausal breast cancer patients who had been on endocrine therapy. Methods: A descriptive correlational study was conducted. Data were collected using questionnaires from 140 patients with breast cancer undergoing endocrine therapy at a general hospital. Data were analyzed using descriptive statistics, t-test, ANOVA, Tukey HSD test, Pearson's correlation analysis and hierarchical regression analysis. Results: The mean scores for menopausal symptom, functional status, and distress were $19.65{\pm}7.86$, $2.67{\pm}0.33$ and $3.69{\pm}2.19$, respectively. The menopausal symptoms and distress were positively correlated (r=.76, p<.001). The menopausal symptoms and functional status (r=-.43, p<.001) and functional status and distress (r=-.31, p<.001) were negatively correlated. The most influential factor for distress was menopausal symptoms (${\beta}=.79$, p<.001). Conclusion: Based on the findings of this study, developing nursing intervention programs focusing on decreasing menopausal symptoms and distress are recommended.

Keywords

Table 1. Demographic and Clinical Characteristics

BGHSBR_2019_v25n1_15_t0001.png 이미지

Table 2. Levels of Menopausal Symptoms, Functional Status, and Distress

BGHSBR_2019_v25n1_15_t0002.png 이미지

Table 3. Menopausal Symptoms, Functional Status, and Distress according to Sociodemographic & Illness related Characteristics

BGHSBR_2019_v25n1_15_t0003.png 이미지

Table 4. Correlation among Menopausal Symptoms, Func-tional Status, and Distress

BGHSBR_2019_v25n1_15_t0004.png 이미지

Table 5. Factors Influencing Distress

BGHSBR_2019_v25n1_15_t0005.png 이미지

References

  1. National Cancer Information Center. Cancer statistics 2017 [Internet]. Goyang: National Cancer Information Center; 2017 [cited 2018 October 1]. Available from: https://www. cancer.go.kr/lay1/S1T639C641/contents.do.
  2. Korean Breast Cancer Society. Breast cancer facts & figures 2017 [Internet]. Seoul: Korean Breast Cancer Society; 2017 [cited 2018 October 1]. Available from: https://www.kbcs.or.kr/journal/file/2017_Breast_Cancer_Facts_and_Figures.pdf.
  3. Korean Breast Cancer Society. The breast. 4rd ed. Seoul: Korean Breast Cancer Society; 2017.
  4. Burstein HJ, Temin S, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, et al. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American society of clinical oncology clinical practice guideline focused update. Journal of Clinical Oncology. 2014;32(21):2255-2269. https://doi.org/10.1200/JCO.2013.54.2258
  5. Kim Y, Min YH. Menopausal symptoms and associated factors in breast cancer patients receiving hormone therapy. Journal of Korean Clinical Nursing Research. 2017;23(1):120-129. https://doi.org/10.22650/JKCNR.2017.23.1.120
  6. Hwang E, Yi M. Factors influencing quality of life in patients with breast cancer on hormone therapy. Journal of Korean Academy of Nursing. 2014;44(1):108-117. https://doi.org/10.4040/jkan.2014.44.1.108
  7. Rosenberg SM, Stanton AL, Petrie KJ, Partridge AH. Symptoms and symptom attribution among women on endocrine therapy for breast cancer. The Oncologist. 2015;20(6):598-604. https://doi.org/10.1634/theoncologist.2015-0007
  8. Dorjgochoo T, Gu K, Kallianpur A, Zheng Y, Zheng W, Chen Z, et al. Menopausal symptoms among breast cancer patients 6 months after diagnosis; a report from the Shanghai breast cancer survival study. Menopause. 2009;16(6):1205-1212. https://doi.org/10.1097/gme.0b013e3181aac32b
  9. Tulman L, Fawcett J, McEvoy MD. Development of the inventory of functional status cancer. Cancer Nursing. 1991;14(5):254-260. https://doi.org/10.1097/00002820-199110000-00005
  10. Ozkan S, Ogce F. Psychometric analysis of the inventory of functional status-cancer(IFS-CA) in Turkish women. Journal of Transcultural Nursing. 2009;20(2):187-193. https://doi.org/10.1177/1043659608330061
  11. Kimmick GG, Lovato J, McQuellon R, Robinson E, Muss HB. Randomized, double-blind, placebo-controlled, crossover study of sertraline(Zoloft) for the treatment of hot flushes in women with early stage breast cancer taking tamoxifen. The Breast Journal. 2006;12(2):114-122. https://doi.org/10.1111/j.1075-122X.2006.00218.x
  12. Boehm DU, Lebrecht A, Eckhardt T, Albrich S, Schmidt M, Siggelkow W, et al. Quality of life and adjuvant tamoxifen treatment in breast cancer patients. European Journal of Cancer Care. 2009;18(5):500-506. https://doi.org/10.1111/j.1365-2354.2008.01015.x
  13. National Comprehensive Cancer Network. NCCN Guidelines & Clinical Resources: NCCN Guidelines for Supportive Care: Distress management [internet]. Plymouth Meeting, PA: National Comprehensive Cancer Network; 2017 [cited 2017 June 15]. Available from: https://www.nccn.org/professionals/physician_gls/default.aspx#supportive.
  14. Ho SS, So WK, Leung DY, Lai ET, Chan CW. Anxiety, depression and quality of life in Chinese women with breast cancer during and after treatment: A comparative evaluation. European Journal of Oncology Nursing. 2013;17(6):877-882. https://doi.org/10.1016/j.ejon.2013.04.005
  15. Jo HC, Kim ET, Min JW. Distress and quality of life for breast cancer survivors during follow- up periods in Korea. Journal of Breast Disease. 2016;4(2):58-63. https://doi.org/10.14449/jbd.2016.4.2.58
  16. Jorgensen L, Laursen BS, Garne JP, Sherman KA, Sogaard M. Prevalence and predictors of distress in women taking part in surgical continuity of care for breast cancer: A cohort study. European Journal of Oncology Nursing. 2016;22:30-36. https://doi.org/10.1016/j.ejon.2016.01.004
  17. Mertz BG, Bistrup PE, Johansen C, Dalton SO, Deltour I, Kehlet H, et al. Psychological distress among women with newly diagnosed breast cancer. European Journal of Oncology Nursing. 2012;16(4):439-443. https://doi.org/10.1016/j.ejon.2011.10.001
  18. Kwon EJ, Yi M. Distress and quality of life in breast cancer survivors in Korea. Asian Oncology Nursing. 2012;12(4):289-296. https://doi.org/10.5388/aon.2012.12.4.289
  19. Seo JY, Yi M. Distress and quality of life in cancer patients receiving chemotherapy. Asian Oncology Nursing. 2015;15(1): 18-27. https://doi.org/10.5388/aon.2015.15.1.18
  20. Ganz PA, Petersen L, Bower JE, Crespi CM. Impact of adjuvant endocrine therapy on quality of life and symptoms: observational data over 12 months from the mind bodystudy. Journal of Clinical Oncology. 2016;34(8):816-824. https://doi.org/10.1200/JCO.2015.64.3866
  21. Sousa MS, Peate M, Jarvis S, Hickey M, Friedlander M. A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy. Therapeutic Advances in Medical Oncology. 2017;9(4):269-285. https://doi.org/10.1177/1758834016687260
  22. Marsden J. The menopause specialist and breast cancer survivorship. Post Reproductive Health. 2016;22(4):147-154. https://doi.org/10.1177/2053369116668738
  23. Mao JJ, Stricker C, Bruner D, Xie S, Bowman MA, Farrar JT, et al. Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer. 2009;115(16):3631-3639. https://doi.org/10.1002/cncr.24419
  24. Yun YH, Mendoza TR, Heo DS, Yoo T, Heo BY, Park HA, et al. Development of a cancer pain assessment tool in Korea: A validation study of a Korean version of the brief pain inventory. Oncology. 2004;66(6):439-444. https://doi.org/10.1159/000079497
  25. Heinemann LA, Potthoff P, Schneider HP. International versions of the Menopause Rating Scale(MRS). Health and Quality of Life Outcomes. 2003;1:28. https://doi.org/10.1186/1477-7525-1-28
  26. Suh EY, Lee EO. The effects of rhythmic walking exercise on physical strength, fatigue, and functional status of breast cancer patients in adjuvant chemohterapy. Korean Journal of Adult Nursing. 1997;9(3):422-437.
  27. Park HJ, Yoon HG. Menopausal symptoms, sexual function, depression, and quality of life in Korean patients with breast cancer receiving chemotherapy. Supportive Care in Cancer. 2013;21(9):2499-2507. https://doi.org/10.1007/s00520-013-1815-6
  28. Cohen PA, Brennan A, Marino JL, Saunders CM, Hickey M. Managing menopausal symptoms after breast cancer: A multidisciplinary approach. Maturitas. 2017;105:4-7. https://doi.org/10.1016/j.maturitas.2017.04.013
  29. Seo MH, Lim KH. The effects of fatigue and distress on self-efficacy among breast cancer survivors. Korean Journal of Adult Nursing. 2016;28(4):378-387. https://doi.org/10.7475/kjan.2016.28.4.378
  30. Park JH, Bae SH, Chun M, Jung YS, Jung YM. Factors influencing elevated distress scores at the end of primary treatment of breast cancer. Asian Oncology Nursing. 2015;15(3):132-139. https://doi.org/10.5388/aon.2015.15.3.132